Fatostatin
Fatostatin is a small molecule inhibitor that blocks SREBP activation by binding to SCAP, preventing SREBP-1 and SREBP-2 translocation from the ER to the Golgi. It is a valuable research tool for studying lipid metabolism and has been used in both in vitro and in vivo models of metabolic disorders, including cancer and fatty liver disease.
Product Specifications
CAS Number
125256-00-0
Product Name Alternative
Mice, ob/ob, inhibit, insulin-induced, human, Inhibitor, gene, Golgi, Fatostatin, Fatty Acid Synthase, Fatty Acid Synthase (FASN), FattyAcidSynthase, expression, cancer, adipogenesis, 125B11, prostate, SREBP, SREBP-mediated
Field of Research
Cell Biology
Purity
>98%
Bioactivity
SREBP activation inhibitor
Form
Powder
Solubility
Soluble in DMSO (up to 25 mg/ml) .
Smiles
CCCc1cc (ccn1) -c1nc (cs1) -c1ccc (C) cc1
Molecular Formula
C18H18N2S
Molecular Weight
294.42
Storage Conditions
RT
Notes
For research use only.
Other Product Names
2- (2-Propylpyridin-4-yl) -4- (p-tolyl) thiazole
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog